Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemia

被引：10
作者：
Hoffman, R
Eliakim, R
Zuckerman, T
Rowe, JM
Brenner, B
机构：
[1] Rambam Med Ctr, Dept Hematol & Bone Marrow Transplantat, IL-31096 Haifa, Israel
[2] Rambam Med Ctr, Inst Gastroenterol, IL-31096 Haifa, Israel
[3] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2003年 / 1卷 / 03期
关键词：
D O I：
10.1046/j.1538-7836.2003.t01-5-00177.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：606 / 608
页数：3
相关论文
共 10 条
[1]   Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study [J].
Bernstein, DE ;
Jeffers, L ;
Erhardtsen, E ;
Reddy, KR ;
Glazer, S ;
Squiban, P ;
Bech, R ;
Hedner, U ;
Schiff, ER .
GASTROENTEROLOGY, 1997, 113 (06) :1930-1937
[2]   Off-label use of recombinant factor VIIa in patients following bone marrow transplantation [J].
Blatt, J ;
Gold, SH ;
Wiley, JM ;
Monahan, PE ;
Cooper, HC ;
Harvey, D .
BONE MARROW TRANSPLANTATION, 2001, 28 (04) :405-407
[3]   Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage [J].
Gerotziafas, GT ;
Zervas, C ;
Gavrielidis, G ;
Tokmaktsis, A ;
Hatjiharissi, E ;
Papaioannou, M ;
Lazaridou, A ;
Constantinou, N ;
Samama, MM ;
Christakis, J .
AMERICAN JOURNAL OF HEMATOLOGY, 2002, 69 (03) :219-222
[4]   Recombinant factor VIIa (NovoSeven®) as a hemostatic agent [J].
Hedner, U .
SEMINARS IN HEMATOLOGY, 2001, 38 (04) :43-47
[5]   The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis [J].
Hoffman, M ;
Monroe, DM .
SEMINARS IN HEMATOLOGY, 2001, 38 (04) :6-9
[6]   Treatment of traumatic bleeding with recombinant factor VIIa [J].
Kenet, G ;
Walden, R ;
Eldad, A ;
Martinowitz, U .
LANCET, 1999, 354 (9193) :1879-1879
[7]   Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII [J].
Moscardó, F ;
Pérez, F ;
de la Rubia, J ;
Balerdi, B ;
Lorenzo, JI ;
Senent, ML ;
Aznar, I ;
Carceller, S ;
Sanz, MA .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (01) :174-176
[8]   Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia [J].
Poon, MC ;
Demers, C ;
Jobin, F ;
Wu, JWY .
BLOOD, 1999, 94 (11) :3951-3953
[9]   Continuous infusion of recombinant factor VIIa in hemophilic patients with inhibitors: Safety, monitoring, and cost effectiveness [J].
Schulman, S .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04) :421-424
[10]   Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII [J].
Vlot, AJ ;
Ton, E ;
Mackaay, AJC ;
Kramer, MHH ;
Gaillard, CAJM .
AMERICAN JOURNAL OF MEDICINE, 2000, 108 (05) :421-423
1